We have found that whereas CB2 Q63R variant is not associated with steatosis or fibrosis, it is associated with the severity of the inflammation (p = 0.002) and the presence of NASH (p = 0.02). The gene discussed is CNR2; the disease is metabolic dysfunction-associated steatohepatitis.